ArticleFrontiers in medicine2026
Comparative machine learning to predict acute kidney injury in traumatic brain injury: a MIMIC-IV cohort with SHAP interpretation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: AKI is a frequent and severe complication among TBI patients. Accurate early prediction is critical but remains challenging in ICU practice. Methods: We retrospectively analyzed the MIMIC-IV database. After screening 85,242 first ICU admissions and applying exclusions, 2,986 TBI patients were included. AKI was defined by KDIGO criteria. Demographic, physiological, laboratory, and intervention variables were extracted, preprocessed, and imputed. Predictors were selected using LASSO, Boruta, and logistic regression with bootstrap validation. Seven ML models (LR, DT, RF, XGBoost, LightGBM, SVM, ANN) were trained on 70% of the cohort and validated on 30%, with hyperparameters optimized by grid search and 5-fold CV. Performance was assessed by AUC, calibration, DCA, accuracy, sensitivity, specificity, PPV, NPV, and Results: Of the 2,986 TBI patients, 2,045 (68.5%) developed AKI. AKI patients were older, heavier, and had higher glucose, sodium, SBP, and temperature, with lower urine output and more frequent ventilation. Feature selection consistently retained urine output, ventilation, weight, age, glucose, sodium, SBP, and temperature as core predictors. In validation, XGBoost showed the best performance (AUC 0.775, 95% CI 0.747-0.802; accuracy 74.4%; sensitivity 88.3%; Conclusion: Ensemble ML models, particularly XGBoost, demonstrated robust predictive power, outperforming LR and DT. The XGBoost model combined high discrimination, calibration, and interpretability, offering a clinically applicable tool for early AKI risk stratification in TBI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.